Elder Pharma to hire 1,000 for rural sales

Image
P B Jayakumar Mumbai
Last Updated : Jan 21 2013 | 2:33 AM IST

Elder Pharmaceuticals plans to recruit 1,000 sales and marketing professionals within two months, mainly to sell drugs in untapped rural markets.

“There has been a revival in demand across pharmaceutical segments, but the real growth story lies in the rural and semi-urban markets, which we expect to grow at about 15 per cent annually from the current level,” said Alok Saxena, director at Elder Pharmaceuticals.

Elder Pharma employs about 3,300 people in India, with about 2,700 professionals in marketing and sales. This recruitment will help Elder Pharma to have one of the largest drug sales force in India, like market leaders such as Cipla, Ranbaxy, Piramal Healthcare and Lupin.

He said the Rs 600-crore company would launch nine-12 new products in this financial year in India. He said in addition to doctors, Elder Pharma had plans to reach out to physicians, specialists and chemists, hospitals, nursing homes and private healthcare institutions in rural and semi-urban areas in a major way.

Elvista, Elder Pharma’s rural division, already has presence in the rural and semi urban markets of Uttar Pradesh, Maharashtra, Andhra, Bengal and Bihar and certain areas in South India.

By December 2012, Elvista plans to reach 1,500 villages, with population of below 40,000, 300 villages with population of 40,000 to 1,00,000 and over 75 peripheral villages and towns around MMR (Mumbai Metropolitan region). Elder sells over 350 products with focus on generics, women’s healthcare, pain management lifestyle diseases.

Elder Pharma, according to drug sales tracking agency ORG IMS, was the fastest growing pharma company in India during 2009 calendar year, said Saxena.

India is likely to become one of the top 10 global pharmaceuticals markets in terms of sales by 2020, with the total value reaching about $50 billion, according to a recent report by PricewaterhouseCoopers (PwC).

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 15 2010 | 12:49 AM IST

Next Story